WICHITA, Kan., Jan. 22, 2017 -- Patients can effectively relieve dry eyes with the advanced technology provided from LipiFlow® gland function treatment. Wichita Optometry is one of the first in the area to offer LipiFlow®, a revolutionary treatment for dry eye disease associated with Meibomian Gland Dysfunction (MGD). MGD is the leading cause of most forms of dry eye disease. Dry eye disease is progressive and may affect individuals of any age. Dry eyes can impair vision and interfere with the ability to read, drive, and perform routine activities.
Dry eye disease is a progressive condition that was once thought to affect only older adults. MGD-related dry eye disease affects people of all ages and is influenced by many factors including use of digital devices and computer-intensive work environments. Research shows that fluctuating vision (blurrier vision at certain times of the day) is one of the most common patient complaints. Other symptoms include irritated, gritty, scratchy, or burning eyes, a feeling of something in the eyes, excess watering, and blurred vision. Without treatment, dry eye disease progresses over time and can affect vision and quality of life.
LipiFlow® is fast, painless and can substantially improve the quality of life for dry eye sufferers. Shown to provide comfort to 86% of dry eye patients, LipiFlow® is the only FDA Cleared technology to address one of the main root causes. Treatments with LipiFlow® undertaken by the end of the year can be covered using remaining FSA/HSA dollars with Dr. Chad Fleming of Wichita Optometry.
“Dry eye is one of the most common complaints I hear from patients, and it’s one that shouldn’t be ignored,” said Chad Fleming, OD, FAAO. “We are pleased to now offer LipiFlow® to help those with MGD. We know that traditional therapies provide limited relief. LipiFlow® can bring comfort back to a dry eye sufferer’s life. Dry eye sufferers can now get effective Meibomian Gland Dysfunction (MGD) treatment in Wichita. I can’t stress enough how important it is to care for your eye health and not let dry eye go untreated.”
Dr. Chad Fleming is one of the optometrists available at Wichita Optometry, serving the vision needs of residents in and around Wichita, KS at one of their two locations on West Douglas Avenue or on North Amidon. Patients can expect friendly and high-quality eye care from staff who address any patient concerns. Services at Wichita Optometry include comprehensive eye exams, eyeglasses, contact lenses, pre- and post-operative care, and treatment of eye diseases including pink eye, diabetic retinopathy, astigmatism, cataracts, glaucoma, macular degeneration, dry eyes, red eyes and amblyopia.
Call (316) 942-7496 for their West Douglas Avenue location and (316) 838-7797 for their North Amidon location to learn more about LipiFlow® gland function treatment. For all suffering from dry eyes in the Wichita area, visit http://www.eyedoctorwichita.com/.
Wichita Optometry, (316) 942-7496


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



